Marketing-authorisation holder · United States
Takeda Pharms USA
49 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
49 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 49
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTOPLUS MET500MG; 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 850MG; 15MG BASE · Tablet | Metformin, Pioglitazone | United States | Marketed | 2005 |
| ACTOPLUS MET XR1gm; 15mg base | 1gm; 30mg base · Tablet, extended release | Metformin, Pioglitazone | United States | Not marketed | 2009 |
| ACTOS15mg base | 30mg base | 45mg base · Tablet | Pioglitazone | United States | Marketed | 1999 |
| ADDERALL XR 102.5mg; 2.5mg; 2.5mg; 2.5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | United States | Marketed | 2001 |
| ADDERALL XR 153.75mg; 3.75mg; 3.75mg; 3.75mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | United States | Marketed | 2001 |
| ADDERALL XR 205mg; 5mg; 5mg; 5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | United States | Marketed | 2001 |
| ADDERALL XR 256.25mg; 6.25mg; 6.25mg; 6.25mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | United States | Marketed | 2001 |
| ADDERALL XR 307.5mg; 7.5mg; 7.5mg; 7.5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | United States | Marketed | 2001 |
| ADDERALL XR 51.25mg; 1.25mg; 1.25mg; 1.25mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | United States | Marketed | 2001 |
| AGRYLIN0.5MG BASE | 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Anagrelide | United States | Marketed | 1997 |
| ALUNBRIG180mg | 30mg | 90mg · Tablet | Brigatinib | United States | Marketed | 2017 |
| CARBATROL100mg | 200mg | 300mg · Capsule, extended release | Carbamazepine | United States | Marketed | 1997 |
| CERADON1gm base/vial · Injectable | Cefotiam | United States | Not marketed | 1988 |
| DEXILANT30mg | 60mg · Capsule, delayed release | Dexlansoprazole | United States | Marketed | 2009 |
| DEXILANT SOLUTAB30mg · Tablet, orally disintegrating, delayed release | Dexlansoprazole | United States | Not marketed | 2016 |
| DUETACT2mg; 30mg | 4mg; 30mg · Tablet | Glimepiride, Pioglitazone | United States | Marketed | 2006 |
| ENTYVIO108mg/0.68ml · Injectable | Vedolizumab | United States | Marketed | 2024 |
| ENTYVIO300mg · Injectable | Vedolizumab | United States | Marketed | 2023 |
| ENTYVIO108mg/0.68ml | 300mg · Injectable | Vedolizumab | United States | Marketed | 2014 |
| EOHILIA2mg/10ml · Suspension | Budesonide | United States | Marketed | 2024 |
| EXKIVITY40mg base · Capsule | Mobocertinib | United States | Not marketed | 2021 |
| FIRAZYR30mg base/3ml (eq 10mg base/ml) · Injectable | Icatibant | United States | Marketed | 2011 |
| FOSRENOL1gm base | 250mg base | 500mg base | 750mg base · Tablet, chewable | Lanthanum carbonate | United States | Marketed | 2004 |
| FOSRENOL1gm base | 750mg base · Powder | Lanthanum carbonate | United States | Marketed | 2014 |
| FRUZAQLA1mg | 5mg · Capsule | Fruquintinib | United States | Marketed | 2023 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 49 | 49 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.